Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Chemoinformatics Core
Neuroactive Steroids and Seizure Control during Pregnancy in Women with Epilepsy
Targeted Capacity Expansion Program for Substance Abuse Treatment
Liquid Chromatography of Biological Substances
Dietary Effects on Lipoprotein Metabolism
Recently added grants:
Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging
Prostaglandin E2, Immunity and hypertension
Deciphering molecular details of cellular sugar transport and their roles in disease
Interaction between leptin and angiotensin in the pathogenesis of obesity-hypertension
Role of Smooth Muscle Calponin in Vascular Pathobiology
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-005
Application #
7329501
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant